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A cell biological determination of Integrator subunit localization

Sarah Beth May, B.S.

Supervisory Advisor: Eric Wagner, Ph.D.

Uridine-rich small nuclear (U snRNAs), with the exception of the U6 snRNA,
are RNA polymerase II (RNAPII) transcripts. The mechanism of 3’ cleavage of
snRNAs has been unknown until recently. This area was greatly advanced when
12 of the Integrator complex subunits (IntS) were purified in 2005 through their
interaction with the C-terminal domain (CTD) of the large subunit (RpbI) of RNAPII.
Subsequently, our lab performed a genome-wide RNAi screen that identified two
more members of the complex that we have termed IntS13 and IntS14. We have
determined that IntS9 and 11 mediate the 3’ cleavage of snRNAs, but the exact
function of the other subunits remains unknown. However, through the use of a U7
snRNA-GFP reporter and RNAi knockdown of the Integrator subunits in Drosophila
S2 cells, we have shown that all subunits are required for the proper processing of
snRNAs, albeit to differing degrees. Because snRNA transcription takes place in
the nucleus of the cell, it is expected that all of the Integrator subunits would exhibit
nuclear localization, but the knowledge of discrete subnuclear localization (i.e. to
Cajal bodies) of any of the subunits could provide important clues to the function of
that subunit. In this study, we used a cell biological approach to determine the
localization of the 14 Integrator subunits. We hypothesized that the majority of
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the subunits would be nuclear, however, a few would display distinct
localization to the Cajal bodies, as this is where snRNA genes are localized
and transcribed.

The specific aims and results are: 1. To determine the

subcellular localization of the 14 Integrator subunits.

To accomplish this,

mCherry and GFP tagged clones were generated for each of the 14 Drosophila and
human Integrator subunits. Confocal microscopy studies revealed that the majority
of the subunits were diffuse in the nucleus, however, IntS3 formed discrete
subnuclear foci. Surprisingly, two of the subunits, IntS2 and 7 were observed in
cytoplasmic foci. 2. To further characterize Integrator subunits with unique
subcellular localizations. Colocalization studies with endogenous IntS3 and Cajal
body marker, coilin, showed that these two proteins overlap, and from this we
concluded that IntS3 localized to Cajal bodies. Additionally, colocalization studies
with mCherry-tagged IntS2 and 7 and the P body marker, Dcp1, revealed that these
proteins colocalize as well. IntS7, however, is more stable in cytoplasmic foci than
Dcp1. It was also shown through RNAi knockdown of Integrator subunits, that the
cytoplasmic localization of IntS2 and 7 is dependent on the expression of IntS1 and
11 in S2 cells.
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Chapter 1:
Introduction

1

Small Nuclear RNAs
Uridine-rich small nuclear (U snRNAs) are a class of ubiquitously expressed
small non-coding RNAs present in all cells. These critical RNAs assemble with
proteins to form small nuclear ribonucleoproteins (snRNPs) and act in concert with
RNA polymerase II (RNAPII) to remove introns from pre-mRNAs and process the 3’
end of histone mRNAs [1, 2]. They include the U1, U2, U4, U5, and U6 snRNAs of
the major spliceosome, the U4atac, U6atac, U11, and U12 snRNAs of the minor
spliceosome, and the U7 snRNA required for histone 3’ end processing [3-5]. All of
these RNAs, with the exception of the RNAPIII-transcribed U6 and U6atac snRNAs,
are transcribed by RNAPII [6, 7].
The snRNA genes can be divided into two classes, the Sm-class consisting
of the U1, U2, U4, U4atac, U5, U7, U11, and U12 snRNAs, and the Lsm-class
consisting of the U6 and U6atac snRNAs.

The Sm-class snRNAs have a 5’-

trimethylguanosine cap, a 3’ stem loop, and an Sm site that serves as the binding
site for the seven Sm proteins. The Sm-class snRNAs are arranged in a similar
manner to mRNA genes and a complex of proteins called the Integrator complex
carries out their 3’ end formation.

In contrast, the Lsm-class snRNAs, U6 and

U6atac, have a monomethylphosphate cap on their 5’ ends and a 3’ stem loop
followed by a stretch of uridines that serves as the binding site for the ring of Lsm
proteins. This stretch of uridines also serves as a RNAPIII transcription terminator
[1].
Multiple copies of the snRNA genes are present in the genome, and they are
typically found in clusters [8-10]. The genes are much simpler than their mRNA-
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encoding counterparts, having no introns or 3’ polyadenylation as well as lacking a
TATA box and an open reading frame [11]. Instead, the promoter contains two
alternative elements, a distal sequence element (DSE) that acts as a transcriptional
enhancer, and a proximal sequence element (PSE) that is required for snRNA
transcription [12]. At the 3’ end of the gene, the 3’ box, with the sequence GTTTN03AAAPuNNAGA where

N is any nucleotide and Pu is a purine, lays 9-19 nucleotides

downstream of the 3’ cleavage site of the mature snRNA and is required for the
proper formation of the snRNA [13-15]. A comparison of a snRNA gene to a typical
mRNA gene is shown in Figure 1.

3’ End Formation of RNA Polymerase II Transcripts
The 3’ end formation of the major RNAPII transcripts: poly(A)+ mRNAs,
histone mRNAs, and snRNAs are similar in many ways, with a few key differences
(Figure 2).

The poly(A)+ pre-mRNAs contain two cis-elements defining their 3’

ends. The first is the AAUAAA polyadenylation signal (PAS), and the second is the
G/U rich downstream element (DSE) [16]. To form the 3’ end, the Cleavage and
Polyadenylation Specificity Factors (CPSFs) are recruited through the binding of
CPSF160 to the PAS [17]. CPSF160 is the only member of the core CPSFs that
possesses an RNA binding domain. The Cleavage-Stimulation Factor (CstF) is also
recruited to the 3’ end through the binding of CstF64 to DSE [18]. Once these two
complexes are in place, they recruit a cleavage factor, which is comprised of
CPSF73 and CPSF100 along with the large scaffolding protein, Symplekin.
CPSF73 contains both a β-CASP and a β-lactamase domain that, together, cleave
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Figure 1: Human snRNA genes vs. mRNA genes.

mRNA genes contain a

promoter, an open reading frame (ORF) and a polyadenylation signal (PAS)
marking their 3’ end. In contrast, snRNA genes have a distal sequence element
(DSE) and a proximal sequence element (PSE) not found in typical mRNA
promoters. They also lack an ORF and have a 3’ box marking their 3’ ends in lieu
of a PAS, as snRNAs are not polyadenylated.
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Figure 2: A comparison of the 3’ end formation of three major RNAPII
transcripts. Poly(A)+ mRNA and histone mRNA are both cleaved by CPSF73 and
100 to form their 3’ ends. The difference between these two transcripts lies in the
cis- and trans-factors that recruit the cleavage factor to the cleavage site. snRNAs,
however, are cleaved by a novel complex of proteins called the Integrator Complex
where the cleavage is carried out by IntS11 and 9, which show homology to
CPSF73 and 100 respectively. No Integrator protein resembling Symplekin has yet
been identified [2].
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the mRNA at a CA cleavage site [16, 19, 20]. A polynucleotide tail of approximately
250 adenine residues is then added by poly(A) polymerase to produce the mature
mRNA.
3’ end formation of histone mRNAs is very similar to that of poly(A)+ mRNAs,
the differences lying in the cis-elements that define the 3’ end and the lack of a
poly(A) tail [21]. Histone mRNAs have a stem loop upstream of the cleavage site
that is bound by the stem-loop-binding protein (SLBP) and a histone downstream
element (HDE) that base pairs with the U7 snRNA of the U7 snRNP [22, 23]. Once
these factors have been recognized, the same cleavage factor that cleaves
poly(A)+ mRNA, CPSF73/ CPSF100, and Symplekin, are recruited to cleave the
histone mRNA [24-26]. Aside from the addition of the 7meGuanosine cap, this is
the only mRNA processing reaction that histone mRNA’s undergo as they are not
polyadenylated.
Similarly to histone mRNA genes, snRNA genes also possess a stem loop
upstream of the 3’ cleavage site, however, in place of the HDE snRNA genes
possess the poorly conserved 3’ box [13].

The 3’ box along with the snRNA

promoter, and the C-terminal domain (CTD) of the largest subunit (Rpb1) of RNAPII
are all required for proper 3’ end formation [15, 27-30]. The transcription cycle of
snRNA genes is highly related to standard mRNA genes with some key exceptions.
When an snRNA gene is going to be transcribed (Figure 3), RNAPII is recruited to
the promoter by the binding of an snRNA-specific complex of proteins termed the
PSE-binding transcription factor (PTF) (also called snRNA activator protein complex
(SNAPc) and PSE-binding protein (PBP)) [11]. Once recruited to the promoter, the
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Figure 3: The Integrator complex mediates snRNA 3’ end processing. The
Integrator complex is recruited to an snRNA gene via phosphorylation of the CTD at
serines 2 and 7 of RNAPII. It then rides along as RNAPII transcribes the snRNA
and is transferred to the nascent snRNA at the 3’ box. Upstream of the 3’ box, the
snRNA is cleaved by IntS11 and 9, which display homology to CPSF73 and 100
respectively [36].
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CTD of RNAPII, which contains multiple repeats of the heptad YS2PTS5PS7, is
phosphorylated at the serine 2 and serine 7 positions of the heptad through the
activity of multiple kinases [31, 32]. The serine 2 kinase cdk9/cyclin T has been
shown to be required for snRNA 3’ end formation and appears likely to be one of
the CTD kinases required. The identity of the serine 7 kinase is more controversial
as both TFIIH and DNA-PK have been shown to possess this activity. Importantly,
neither of these kinases has been shown to be functionally required for snRNA 3’
end formation. This phosphorylation is thought to then recruit a recently purified
complex of proteins called the Integrator complex to the CTD of RNAPII [33, 34].
The Integrator complex is speculated to associate with RNAPII as it transcribes, and
is transferred to the nascent snRNA at the 3’ box. Once at the 3’ box, cleavage is
carried out upstream by Integrator subunits (IntS) 11 and 9, which exhibit homology
to CPSF73 and CPSF100 respectively [33, 35, 36]. Interestingly, it has not been
shown that Symplekin or a Symplekin-like protein is a member of the Integrator
complex or that any of the Integrator subunits display any homology to Symplekin,
nor is in known how the Integrator complex mediates snRNA cleavage [2].

The Integrator Complex
In 2005, the Shiekhattar laboratory discovered the Integrator complex in a
pull-down experiment to find proteins that interacted with the Deleted in Split
hand/Split foot (DSS1) protein. They purified the complex and found that it was
comprised of 12 subunits and associated with the CTD of the largest subunit (Rpb1)
of RNAPII [33]. Subsequent purifications performed by the Shiekhattar laboratory,
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in which they use flag-tagged IntS10 to pull down and purify the complex as well as
a more recent purification by a separate group using specific antibodies against
Integrator subunits failed to pull down DSS1, showing that its ability to pull down the
Integrator complex in the first purification was serendipitous and it is not in fact a
member of the Integrator complex [33, 37].
In addition to its interaction with the CTD, it was also shown that the
Integrator complex mediates 3’ end processing of snRNAs through the use of RNA
interference (RNAi).

When IntS11 or IntS1 was knocked down via RNAi, an

accumulation of misprocessed snRNA, which migrates slower than normal snRNA,
and is therefore longer, was observed via Northern blot. This is evidence that when
the Integrator complex is compromised, primary snRNAs are not cleaved properly at
the 3’ end, longer misprocessed forms are allowed to accumulate, leading to the
conclusion that the Integrator complex mediates snRNA 3’ end processing [33].
The involvement of the Integrator complex was further demonstrated in a
study by the Wagner laboratory in which a reporter system was developed in
Drosophila S2 cells that placed the green fluorescent protein (GFP) gene and a
PAS downstream of the 3’ box of the U7 snRNA gene. When transfected into
normal cells, any U7 snRNAs transcribed from the reporter plasmid will be cleaved
upstream of the 3’ box and no GFP will be expressed. However, when the reporter
is transfected into cells in which the Integrator complex has been compromised
through RNAi of Integrator subunits, the U7 snRNA will not be properly cleaved. As
a result, RNAPII will read-through to the PAS and GFP will be expressed in these
cells, indicating that snRNAs are being misprocessed. With this tool, it was shown
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that depletion of each Integrator subunit causes misprocessing of snRNAs, albeit to
differing degrees. It was observed that knockdown of IntS1, 4, and 9 caused strong
expression of GFP and therefore high misprocessing of snRNA, knockdown of
IntS5, 7 and 11 yielded and intermediate response, knockdown of and IntS2, 6, 8,
10, and 12 a weak response, while the knockdown of IntS3 resulted in no
detectable misprocessing.

The group confirmed these results using a RT-PCR

assay with forward primers designed to the U7snRNA and reverse primers
designed downstream of the cleavage site [38].

In addition to the Drosophila

assays, the Wagner laboratory has also developed similar human assays that are
yielding similar results.
As mentioned previously, two Integrator subunits, IntS11 and 9 bear
homology to CPSF73 and 100, the cleavage factor for poly(A)+ mRNAs and histone
mRNAs [33, 35]. This is especially true in the β-CASP and β-lactamase domains
present in both sets of proteins, where the amino acid sequences of core elements
within IntS11/CPSF73 and IntS9/CPSF100 are almost exactly alike. Both IntS11
and CPSF73 contain a β-CASP (metallo-β-lactamase-associated CPSF Artemis
SNM1/PSO2) β-lactamase domain, which is essentially a β-lactamase domain that
has been modified to allow the endonucleolytic cleavage of nucleic acids. IntS9 and
CPSF100 also contain a β-CASP β-lactamase domain, however, it has been
modified so as to render it inactive [2, 35]. Baillat et al. determined that IntS11 was
the catalytic subunit of the Integrator complex by overexpressing a mutant IntS11
that lacked catalytic activity in the β-CASP domain. However, it still interacted with
other Integrator subunits and was shown to localize to snRNA genes at both the
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promoter and the 3’ end. When the mutant IntS11 was overexpressed following
depletion of endogenous IntS11, sizable amounts of misprocessed snRNA were
observed, leading to the conclusion that IntS11 is in fact the subunit responsible for
snRNA cleavage [33].
When it was first purified, the Integrator complex was thought to consist of 12
subunits, however, a genome wide RNAi screen preformed in Drosophila S2 cells
found two more subunits, bringing the total up to 14. The complex is evolutionarily
conserved among metazoans; however, there are no Integrator orthologues in the
yeast Saccharomyces cerevisiae as the Nrd1/Nab3/Sen1 complex mediates snRNA
3’ end formation in this species [2, 39, 40].

A schematic of the 14 Integrator

subunits mapping domains identified by Pfam analysis (in green) is shown in Figure
4. In addition to the β-CASP β-lactamase domains found in IntS9 and 11, the only
other identifiable domains to be found in the complex are the armadillo repeats
(ARM) found in IntS4 and 7, the HEAT repeats found in IntS4, the von Willebrand
factor A domains found in IntS6 and 14, the RNA DEAD box helicase (DEAD) (likely
inactive, as key residues are mutated) also in IntS6, the tetratricopeptide repeats
(TPR) in Int8, and the plant homeodomain (PHD) finger in Int12. Armadillo, HEAT,
and TPR repeats as well as von Willebrand factor A domains are all involved in
protein-protein interactions as well as intracellular transport, and the PHD finger is a
chromatin binding domain. The domain of unknown function (DUF) regions are
areas that Pfam has identified as functional domains, however, the exact function of
these regions is unknown. Surprisingly, none of the subunits display any known
RNA binding domains [2].

14

Figure 4: Schematic of Integrator complex subunits.

The areas shaded in

green are protein domains identified through Pfam analysis. Areas in orange are
areas of high homology. Surprisingly, none of the domains identified are known
RNA binding domains [2].
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Since its purification, many members of the Integrator complex have been
implicated in other studies, either for their role in snRNA expression, or for other
functions, suggesting that Integrator proteins may play roles in other processes.
For example, knockdown of IntS1 in mouse embryos results in lethality, and further
examination of the embryos shows an increase in misprocessed snRNAs [41].
Another study has shown that when IntS5 expression is inhibited in zebrafish they
fail to develop circulating blood cells. This is because the lack of functional snRNAs
brought on by the disruption in the Integrator complex leads to splicing defects in
the mRNAs of proteins necessary for hematopoeisis [42]. IntS3 has been shown to
function as part of the sensor of single-stranded DNA (SOSS) complex responsible
for the detection of double-stranded breaks in DNA, and IntS6 has been determined
to be a previously described tumor suppressor gene discovered in non-small-celllung carcinoma, deleted in cancer 1 (DICE1), which, when overexpressed in
prostate cancer cells leads to a reduction in colony formation and cell cycle arrest
[43-46]. These studies suggest the possibility that some Integrator subunits may
also play role in cellular processes other that snRNA expression.

snRNP Biogenesis
All U snRNAs are members of the U small nuclear ribonucleoproteins
(snRNPs), the majority of which function as part of the major and minor
spliceosomes that excise introns out of pre-mRNAs.

The exception is the U7

snRNP, which plays a role in the 3’ end formation of histone mRNAs. A brief
description of snRNP biogenesis (Figure 5) begins in the nucleus with the
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Figure 5: The biogenesis of U snRNPs. snRNP biogenesis begins in the nucleus
with the transcription of snRNAs, usually associated with a Cajal body. The snRNA
is then transported out of the nucleus to the cytoplasm where snRNP proteins are
assembled onto the snRNA by the survival of motor neurons (SMN) complex. Once
the proteins are properly assembled, the snRNP is then transported back to the
nucleus were it first returns to the Cajal body for further processing and is then
transported to the nuclear speckles to participate in splicing [47].
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transcription and 3’ end formation of the snRNAs.

The snRNAs are then

transported into the cytoplasm of the cell where a complement of proteins is
assembled onto the snRNA to form a preliminary snRNP.

The snRNP is then

transported back to the nucleus for further processing before it assumes its function
as part of the spliceosome [47]. This is the case for all of the U snRNPs with the
exception of the U6 snRNP whose assembly takes place solely in the nucleus [48,
49]. A more detailed account of snRNP biogenesis is given below.
As stated previously, snRNA genes, usually found clustered adjacent to Cajal
bodies [50] are transcribed by RNAPII to begin the snRNP biogenesis process. A
complex of proteins called the cap-binding complex (CBC), which consists of the
proteins CBP20 and CBP80, associates co-transcriptionally with the 5’ 7methylguanosine (7mGpppN) cap of the snRNA [51].

Next, an adaptor protein

termed phosphorylated adaptor for RNA export (PHAX) binds to the CBC. PHAX
contains a leucine-rich nuclear export signal (NES) that is only active when PHAX is
phosphorylated [52].

Once a phosphorylated PHAX is bound to the snRNA,

Chromosome Region Maintenance 1 (CRM1), a nuclear export factor, binds to the
exposed NES of PHAX along with the small G-protein, RanGTP, and shuttles the
snRNA out of the nucleus [47, 53].
Once the complex enters the cytoplasm, PHAX is dephosphorylated by
protein phosphatase 2A releasing CRM1 and RanGTP, however, it remains with the
CBC/snRNA complex most likely until the monomethylated (m1G)

7m

G cap is

trimethylated (m3G cap) to prevent the snRNA from interacting with the translation
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initiation machinery [47, 54]. The large SMN complex made up of the SMN protein,
Gemin 2-8, and multiple other proteins then associates with the CBC/snRNA
complex and monitors all maturation events that take place in the cytoplasmic
phase of snRNP assembly [55, 56]. The first of these events is the assembly of the
Sm ring around the Sm site of the snRNA. A set of seven Sm proteins, B/B’ (B’ is a
splice variant of B), D1, D2, D3, E, F, and G form a ring around a conserved
sequence called the “SM binding site” (PuAU4-6GPu) upstream of the snRNA 3’
stem loop [57]. By themselves, the proteins exist as dimers or trimers as they
cannot form a ring in the absence of snRNA. To load the Sm proteins onto the
snRNA, SMN first facilitates the formation of an open ring consisting of D1, D2, E,
F, and G. The SMN complex then loads this complex on to the snRNA Sm site, and
closes the ring with the addition of the B/B’-D3 dimer. After the Sm ring is in place,
trimethyl

guanosine

synthase

1

(Tgs1),

an

SMN

complex-associated

methyltransferase, recognizes B/B’ and the m1G cap which prevents snRNAs
without a complete Sm ring from being hypermethylated as the B/B’-D3 dimer is the
last of the Sm proteins to be added to close up the ring. Tgs1 then transfers two
methyl groups to position 2 of the m1G cap to form the 2,2,7-trimethylguanosine
(m3G) cap. The 3’ end of the snRNA then undergoes further nucleolytic trimming to
form a mature length snRNA [47, 58-61]. Snurportin-1 (SPN1) along with the import
receptor Importin-β (Imp β) then interacts with the m3G cap and the Sm core, which
acts as a nuclear localization signal (NLS) and imports the snRNP back into the
nucleus [47].
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Upon reentry to the nucleus, SPN1 and Imp β disassociate from the snRNP
and return to the cytoplasm, however the SMN complex remains attached. The
snRNP then returns to the Cajal body, where further modifications occur, such as
pseudouridylation and 2’-O-methylation, carried out by small Cajal body RNAs
(scaRNAs) [62, 63]. The SMN complex disassociates from the snRNP at an as yet
unidentified stage in the nuclear maturation process and returns to the cytoplasm,
and the mature snRNP is recruited to subnuclear domains called nuclear speckles
where splicosomal snRNPs are stored, or, as is the case of the U7 snRNP, to
histone locus bodies [3, 47].

Subcellular Localizations of RNPs
Ribonucleoproteins (RNPs) often concentrate, both in the nucleus and the
cytoplasm, into subcellular foci that can be visualized under a light microscope.
While the motives and mechanism behind the formation of these foci is largely
unclear, it is possible that they function to concentrate factors necessary for certain
RNA processing events such as, intron splicing, 3’ end formation, transcription, and
decay. Because the Integrator complex is responsible for the 3’ end processing of
snRNAs we hypothesized that some of the subunits would be present in some of
these nuclear foci, and while this was shown to be the case, some of the subunits
were unexpectedly shown in cytoplasmic foci as well. Possible locations of these
Integrator foci include, Cajal bodies, nuclear speckles, and histone locus bodies in
the nucleus, and P bodies, stress granules, and U bodies in the cytoplasm will be
discussed below [64-66].
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Cajal Bodies
First described in 1903 by Ramon y Cajal, Cajal bodies are dynamic, small
nuclear bodies that are enriched with the protein coilin [65]. In addition to coilin, the
U snRNPs are also enriched in Cajal bodies as well as the SMN complex, which
point to a function in snRNP processing, and Cajal bodies contain small Cajal bodyspecific RNAs called scaRNAs which are responsible for carrying out 2’-Omethlyation and pseudouridylation modifications on the snRNAs of snRNPs once
they reenter the nucleus [62, 67]. Cajal bodies have also been shown to localize to
snRNA gene clusters [50, 68, 69], and are sites of active snRNA transcription [70].
The Ohno laboratory has recently shown that Cajal bodies also play a role in
snRNP assembly prior to its transport into the cytoplasm as well [71]. Their findings
demonstrate that Cajal bodies monitor the export of snRNAs out of the nucleus after
transcription. When PHAX, the NES-containing adaptor protein, is blocked from
binding to nascent snRNAs, the snRNAs are retained in the Cajal body and
prevented from exiting to the cytoplasm [71]. Despite its standard use as a marker
of Cajal bodies, the cellular function of coilin is unknown. Cells lacking coilin, no
longer form Cajal bodies, meaning coilin is necessary for Cajal body structure,
however, snRNP modifications are carried out normally, demonstrating that Cajal
bodies are not necessary for proper snRNP maturation [65]. In addition to snRNP
processing, Cajal bodies are also storage sites for telomerase RNA during
quiescent phases of the cell cycle. During S phase, when telomeres are being
elongated, the telomerase RNA then moves to the telomerase holoenzyme at the
telomeres [72-74].
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Histone Locus Bodies
Histone locus bodies are so called, because they associate with the histone
genes on chromosome 1 or 6 and are enriched for factors required for histone
mRNA 3’ end processing, such as, the U7 snRNP, SLBP, and Symplekin [75, 76].
The existence of these domains was revealed through experiments to visualize
Cajal bodies in Drosophila cells.

The sequence to Drosophila coilin was not

available at the time, so the group used probes to the U7 snRNP and the U85
scaRNA. These probes revealed two separate types of subnuclear foci. The Cajal
bodies were determined to be the ones that contained both the U7 snRNP and the
U85 scaRNA, and the others, containing only the U7 snRNP were termed the
histone locus bodies because of their association with histone genes [77].

As

previously mentioned, histone locus bodies form around replication-dependent
histone gene clusters.

These genes are only active during S phase, and it is

thought that these nuclear bodies serve to concentrate factors necessary for the
maturation of histone mRNAs.

The histone locus bodies are visible until early

prometaphase and then disintegrate in metaphase. Once the new cells enter G1
phase, a few histone locus bodes reform, and their numbers increase upon the
entrance of S phase [78]. Histone locus bodies are usually seen adjacent to Cajal
bodies, however, the relationship between these subnuclear domains is unknown
[65].
Nuclear Speckles
Nuclear speckles, also known as interchromatin granule clusters (IGCs), are
sites enriched in mature U snRNPs and function in pre-mRNA splicing. In addition
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to snRNPs, nuclear speckles also contain serine/arginine-rich (SR) proteins whose
phosphorylation state regulates the interaction of the snRNPs with the spliceosome
as well as sites of transcriptionally active genes. Each nucleus typically contains
approximately 30-50 nuclear speckles, which can travel around the nucleus to
associate with actively transcribing genes [64, 66].

P Bodies
The cytoplasmic foci that later became known as P bodies, were first
observed by the Achsel laboratory in 2002. In this paper, it was shown that LSm17, an mRNA decapping activator complex, Dcp1/2, a decapping enzyme, and the
exonuclease Xrn1 all co-localize to discrete cytoplasmic foci [79]. In 2003, Sheth
and Parker showed that many mRNA decapping and decay factors were present in
these cytoplasmic foci in yeast, including, Dcp1p, Dhh1p, and Xrn1p and
hypothesized that these foci either might be storage sites for mRNA decay factors,
or sites of active mRNA decapping and decay. They called these foci processing
bodies, or P bodies. If P bodies were active sites of decapping and decay, then the
group speculated that inhibiting mRNA decay before the decapping step should
reduce the number of P bodies.

This was because blocking decapping would

reduce the number of mRNAs targeted for decay, and more mRNAs would remain
in polysomes.

Conversely, blocking mRNA decay at or after decapping would

increase the number of P bodies because the mRNA could be targeted for decay,
however, disruption of the decay machinery would cause targeted mRNAs to
accumulate in more and more P bodies. Knockout experiments proved this to be
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true. In a ccr4Δ strain, which is deficient in deadenylation (before decapping), P
bodies are reduced, however, in dcp1Δ (at decapping) and xrn1Δ (after decapping)
strains P bodies increase in both size and number [80].
In addition to decapping factors and exonucleases, proteins involved in other
mRNA decay processes also accumulate in P bodies.

Proteins involved in

nonsense-mediated decay (NMD), which is responsible for the decay of mRNAs
with premature stop codons (nonsense codons), as well as proteins involved in AUrich element (ARE)-mediated decay have been found to accumulate in P bodies
[81-85].

Additionally, the Argonaute and GW proteins involved in RNAi and

microRNA (miRNA)-mediated gene silencing, and translational repressors such as
eIF4E-transporter, the yeast Dhh1 and its vertebrate orthologue RCK/p54
accumulate in P bodies [86-90]. P bodies have additionally been shown to be sites
of replication for RNA viruses as well as sites of host viral defense [91, 92].
P bodies require translationally repressed mRNPs in order to form, and RNAi
and miRNA silencing pathways produce a significant portion of these mRNPs [93,
94].

Izaurralde and colleagues have shown that inhibition of miRNA silencing

pathways and, to lesser extent, RNAi pathways also prevents the formation of
visible P bodies.

However, simply releasing mRNPs from polysomes with

puromycin treatment, which mimics an aminoacylated tRNA and triggers release of
the mRNA from the ribosome when the drug enters the A site, is not sufficient to
restore P bodies in cells with inhibited silencing pathways. The mRNPs must enter
silencing and decay pathways for P bodies to form. Even though P bodies require
silencing pathways to form, silencing pathways do not require P bodies to function,
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as depletion of non-silencing P body components disrupts the formation of P
bodies, but not the function of miRNA silencing pathways.

Therefore, P body

formation is a consequence of silencing pathway function [94].
While the exact mechanism of P body assembly is unknown, many P body
components contain Q/N rich prion-like domains, and it is hypothesized that proteinprotein interactions between these domains play a role in P body aggregation along
with other possible mechanisms [93, 95]. Additionally, other proteins with prion-like
domains, such as the huntingtin (Htt) protein have also recently been shown to
accumulate in P bodies [96].
Stress Granules
Non-translating mRNPs may also form into another type of cytoplasmic foci
called stress granules. These granules are composed of mRNPs that are stalled in
translation initiation as well as initiation factors eIF4E, eIF4G, eIF4A, eIF3 and eIF2,
the small, 40S, ribosomal subunit, and the poly(A) binding protein (Pab1). Stress
granules form in response to environmental stresses such as heat shock, hypoxia,
glucose deprivation, and viral infection [97]. Similar to P bodies, the exact assembly
mechanism of stress granule formation is unknown, though self-aggregation
domains in some components are thought to play a role in this process [98, 99].
Stress granules are also often observed adjacent to P bodies, which lead Balagopal
and Parker to propose a model for cytoplasmic mRNA metabolism they call the
mRNA cycle (Figure 6) [93].

In this model, they suggest that mRNAs in the

cytoplasm cycle between three different states: actively translating in polysomes,
translationally repressed or decaying in P bodies, and stalled in initiation in stress
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Figure 6: The mRNA cycle. Balagopal and Parker have proposed a model of
cytoplasmic mRNA metabolism whereby mRNAs are shuttled between three sites:
polysomes, P bodies, and stress granules [93].
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granules. The recruitment of translational repressors, such as Dhh1 and Pat1 along
with ribosomal run off transition the mRNA to a non-translating state. They can then
aggregate into P bodies where they are stored to reenter a translating state in the
future, decapped by Dcp1/2 and degraded, or transferred to stress granules.
mRNAs stalled in initiation aggregate in stress granules. From here they can either
reenter into polysomes once the stress has passed or be transferred to P bodies
[93].
U Bodies
A third type of cytoplasmic foci is the recently described U body. These
granules were first observed by Liu and Gall in Drosophila nurse cells using
immunofluorescent staining and in situ hybridization. YFP-tagged Lsm11, an Sm
core protein unique to the U7 snRNP, was expressed in transgenic flies, and in
addition to the histone locus bodies found in the nucleus, the proteins were also
observed in cytoplasmic foci.

Immunofluorescent staining using antibodies to

endogenous Lsm11 as well as Lsm10 confirmed this result. In situ hybridization
was then performed using probes against U1, U2, U4, U5, and U6, snRNAs, and all
were found to be present in these cytoplasmic foci as well. These results led to the
term U bodies. U bodies were also shown to contain the SMN protein. In addition,
flies that are homozygous for a mutant form of the arginine methyl transferase Dart5
lack detectable U bodies.

Dart5 is responsible for the conversion of arginine

residues of Sm proteins to symmetrical dimethylarginine (sDMA) leading to
enhanced interaction between SMN and the Sm proteins. U bodies always occur in
conjunction with P bodies although not all P bodies interact with U bodies, and
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disruption of P bodies also leads to disruption of U bodies, suggesting a functional
interaction between these two structures. These data led to the proposal that U
bodies are either sites for certain steps in snRNP assembly or sites of cytoplasmic
snRNP storage before import into the nucleus.

P bodies might interact with U

bodies to regulate the release of snRNPs from the U bodies to the nucleus, or they
might be sites of decay for dysfunctional or unnecessary snRNPs [100].

Summary of Work
This study investigates the subcellular localizations of the Integrator subunits
and seeks to determine if any exhibit unique localizations that might lead to further
information about their function. The hypothesis of this work is that the majority
of subunits will display general nuclear localization, however, a few will have
distinct localization to the Cajal bodies, as this is where snRNA are localized
and transcribed. To test this hypothesis, two specific aims were addressed. The
first specific aim was to determine the subcellular localization of the 14
Integrator subunits. To do this, all Integrator subunits from both Drosophila and
human were cloned either N-terminal or C-terminal to cDNA encoding either
mCherry or GFP to generate fusion proteins. These clones were subsequently
transfected into HeLa or S2 cells and their expression and localization was then
visualized using confocal microscopy. The majority of the subunits were found to
be diffusely expressed in the nucleus, however, IntS3 localized in discrete foci in the
nucleus, and IntS2 and 7 surprisingly formed cytoplasmic foci.

The second

specific aim was to further characterize those Integrator subunits that
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demonstrated a unique subcellular localization.

A variety of experiments,

including co-localization studies, deletions, and RNAi knockdowns were preformed
with IntS2, 3 and 7, and our data suggests that IntS3 localizes to the Cajal bodies,
consistent with its function in snRNA 3’ end processing, and while still present in the
nucleus, both IntS2 and 7 also localize to cytoplasmic P bodies, suggesting they
either play a role in snRNA decay or another cellular function unrelated to snRNA
and snRNP biogenesis. These results have demonstrated the localizations of the
Integrator subunits, revealing unique localizations for three members of this
complex. Further investigation of these subunits in context of these localizations
will lead to increased understanding of Integrator complex function in snRNA and
snRNP biogenesis, and may lead to the discovery of Integrator involvement in other
cellular processes.
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Chapter 2:
Materials and
Methods
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Cell Culture
The human cervical cancer derived cell line, HeLa, was obtained from the
laboratory of Dr. Phillip Carpenter.

These cells were maintained in DMEM

Glutamax-1 high glucose media from Invitrogen, (Carlsbad, CA) supplemented with
10% FBS and 1% Penicillin-Streptomycin at 37°C with 5% CO2. D.Mel-2 (S2) cells,
were obtained from Invitrogen, and are derived from late-stage Drosophila
melanogaster embryos and conditioned to grow in serum free environments. These
cells were maintained in Sf-900 II SFM serum free media (Invitrogen) at 28°C. E.
coli XL1 Blue competent cells were grown in Luria broth (LB) at 37°C, and ampicillin
was added at 50 µg/mL as needed.

Transfections
Transient transfections of human cell lines were performed using the
Lipofectamine 2000 transfection reagent from Invitrogen. Briefly, cells were plated
in 6-well plates at 2.5×105 cells/well and allowed to attach overnight. To prepare
the DNA for transfection, 100-500ng/well of plasmid DNA was added to 100µL/well
of Opti-MEM reduced serum media (Invitrogen) in tube A.

In tube B 2µL/well

Lipofectamine 2000 was mixed with 100µL/well Opti-MEM.

These tubes were

incubated for 7 minutes after which the contents of the two tubes were mixed and
allowed to incubate for another 25 minutes. 200µL of the DNA/Lipofectamine 2000
solution was then added to each well to be transfected. Transient transfections of
the Drosophila S2 cell line were carried out using the Effectene transfection reagent
from Qiagen (Hilden, Germany) according to the manufacturer’s protocol.
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Cloning Reactions
Insert DNA was generated through PCR by using the primer sets found in
Tables 1-5.

The amplified DNA was then purified using the GeneJET PCR

purification system from Fermentas (now part of Thermo Scientific, Glen Burnie,
MD) according to the manufacturer’s protocol. Digests of the vector and insert DNA
were carried out using Fermentas FastDigest restriction enzymes. To digest the
vector: 1-3µg of the vector DNA was mixed with 10µL of the 10X FastDigest buffer
and 1µL of each restriction enzyme. The volume of the reaction was then brought
up to 100µL with dH2O and incubated at 37°C for 10-15 minutes. To digest the
insert: the PCR product eluted from the purification column (≈ 48µL) was mixed with
6µL 10X FastDigest buffer, 4µL of dH20, and 1µL of each restriction enzyme and
incubated at 37°C for 10-15 minutes. Once the vector had been digested, 1µL of
Fermentas FastAP alkaline phosphatase was added to the reaction mixture and
incubated for an additional 10 minutes. To purify the digested vector and insert
DNA, it was first run on a 1% agarose gel. The gel containing the DNA was then
excised, and purified using the GeneJET PCR purification system. To ligate the
vector and insert DNA, a ligation reaction was set up consisting of 4µL of vector
DNA, 4µL of insert DNA, 1µL of 10X ligation buffer, and 1µL of T4 DNA ligase
(purified by the Wagner Laboratory). A control, vector alone, reaction with dH20 in
place of the insert DNA, was also set up at this time, and these reactions were
incubated at room temperature for 4-24 hours. 5µL of each ligation reaction was
then transformed into XL1 Blue competent E. coli cells and plated on LB agar plates
containing ampicillin. Approximately 16 hours later, 5mL cultures of picked colonies
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were set up and allowed to grow overnight. The plasmid DNA was recovered from
these cultures using the Fermentas GeneJeT plasmid miniprep kit. The plasmids
were then screened by restriction digest using the restriction enzymes used to clone
the plasmid.

Generation of Tagged Integrator Clones
Human clones
To generate the human tagged Integrator clones, mCherry and GFP cDNAs
were first cloned into the pcDNA4/TO/myc-His A vector from Invitrogen using the
primers listed in Table 1. mCherry and GFP were inserted so as to create four new
vectors to allow the fluorescent tags to be placed either N-terminal or C-terminal to
the Integrator subunit subsequently cloned. Inserts for the Integrator subunits were
then prepared using the primers listed in Table 2 and were cloned into the mCherry
and GFP vectors using the restriction sites listed.
Drosophila clones
Because the commercially available pIZ/V5-His vector (Invitrogen) suitable
for use in insect cells yields weak protein expression, a new, more robust
expression vector was created for this project.

To do this, first, the strong

Drosophila Ubiquitin 63E (Ubi63E) promoter [101] was cloned into the pUC 19
vector. Downstream of this promoter, the multiple cloning site (MCS) of the pIZ/V5His vector was inserted. Finally, mCherry cDNA was cloned into the pIZ MCS to
generate the new pUB Cherry vector (Figure 7). The primers used for the synthesis
of this vector are listed in Table 3. The Integrator subunits were then cloned into
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Table 1: Primers sets and restriction enzymes used to generate pcDNA4 N/Cterminal mCherry and GFP vectors.
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Primer
Sets

Primer Sequence
(5’-3’)

Restriction
Site

N-GFP F
N-GFP R

GGCCAAGCTTATGGTGAGCAAGGGCGAGGAG
GGCCGGATCCCTTGTACAGCTCGTCCATGCC

HindIII
BamHI

C-GFP F
C-GFP R

GGCCTCTAGAGATGGTGAGCAAGGGCGAGGAG
GGCCACTAGTTCACTTGTACAGCTCGTCCATGCC

XbaI
SpeI

N-mCherry F
N-mCherry R

GGCCAAGCTTATGGTGAGCAAGGGCGAGGAGGAT
GGCCGGATCCCTTGTACAGCTCGTCCATGCC

HindIII
BamHI

C-mCherry F
C-mCherry R

GGCCTCTAGAGATGGTGAGCAAGGGCGAGGAGGAT
GGCCACTAGTTTACTTGTACAGCTCGTCCATGCC

XbaI
SpeI
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Table 2: Primer sets and restriction enzymes used to generate mCherry and
GFP tagged human Integrator subunit clones. Stop = stop codon included in
this primer. Reverse primers that contain stop codons were used to generate Nterminal clones and primers lacking stop codons were used to generate C-Terminal
clones.
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Primer
Sets

Primer Sequence
(5’-3’)

Restriction
Site

IntS2 F
IntS2 R (Stop)
IntS2 R

GGCCGCGGCCGCATGACGCCCGAGGGTACAGGC
GGCCACTAGTCTTTAAATTCCACTAACACTCATGTT
GGCCACTAGTCTAATTCCACTAACACTCATGTT

NotI
SpeI
SpeI

IntS3 F
IntS3 R (Stop)
IntS3 R

GGCCGAATTCATGGAGTTGCAGAAGGGAAAAG
GGCCCTCGAGCGTTAGTCACTGTCAGAGCCCACTGC
GGCCCTCGAGCGGTCACTGTCAGAGCCCACTGC

EcoRI
XhoI
XhoI

IntS4 F
IntS4 R (Stop)
IntS4 R

GGCCGCGGCCGCATGGCGGCGCACCTTAAGAAG
GGCCTCTAGACTTTAGCGCCGTGCAGGTTTGGGCA
GGCCTCTAGACTGCGCCGTGCAGGTTTGGGCA

NotI
XbaI
XbaI

IntS5 F
IntS5 R (Stop)
IntS5 R

GGCCGAATTCTATGTCCGCGCTGTGCGACCCT
GGCCCTCGAGCGCTACGTCCCCTGTCGAAGGAGAGT
GGCCCTCGAGCGCGTCCCCTGTCGAAGGAGAGT

EcoRI
XhoI
XhoI

IntS6 F
IntS6 R (Stop)
IntS6 R

GGCCGAATTCTATGAACCAGCGCAGCCATCTG
GGCCTCTAGACTTTAATTGCTATTAATATGGGTGAT
GGCCTCTAGACTATTGCTATTAATATGGTTGAT

EcoRI
XbaI
XbaI

IntS7 F
IntS7 R (Stop)
IntS7 R

GGCCGAATTCTATGGCGTCAAACTCAACTAAG
GGCCTCTAGACTTTAAAACCGTGTGTAGGCATT
GGCCTCTAGACTAAACCGTGTGTAGGCATT

EcoRI
XbaI
XbaI

IntS9 F
IntS9 R (Stop)
IntS9 R

GGCCGCGGCCGCATGAAACTGTATTGCCTGTCA
GGCCTCTAGACTTTAGAACTTTGTAAGAATTT
GGCCTCTAGACTGAACTTTGTAAGAATTT

NotI
XbaI
XbaI

IntS10 F
IntS10 R (Stop)
IntS10 R

GGCCGCGGCCGCATGTCTGCCCAGGGGGACTGC
GGCCTCTAGACTTTAGGTCAGAGTCTGAAGGAG
GGCCTCTAGACTGGTCAGAGTCTGAAGGAG

NotI
XbaI
XbaI

IntS11 F
IntS11 R (Stop)
IntS11 R

GGCCGGATCCATGCCTGAGATCAGAGTCACG
GGCCTCTAGACTTTAGCTGGGGGCCTGGGGGAG
GGCCTCTAGACTGCTGGGGGCCTGGGGGAG

BamHI
XbaI
XbaI

IntS12 F
IntS12 R (Stop)
IntS12 R

GGCCGGATCCATGGCTGCTACTGTGAACTTG
GGCCTCTAGACTTTACTTCTTGAGTTTCTTTTGGGC
GGCCTCTAGACTCTTCTTGAGTTTCTTTTGGGC

BamHI
XbaI
XbaI
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Figure 7: Diagram of pUB Cherry vector. The ubiquitin 63E promoter (Ubi63E)
was first cloned into a HindIII restriction site in the pUC19 vector. The multiple
cloning site (MCS) from the pIZ/V5-His vector was then cloned in using HindIII and
NdeI restriction sites. Finally mCherry was cloned into the piZ MCS using HindIII
and BamHI restriction sites to give the pUB Cherry vector. Amp – ampicillin, PAS –
polyadenylation signal. Note: the HindIII and XhoI sites that are found in the native
Ubi63E promoter were destroyed to facilitate cloning.
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Table 3: Primer sets and restriction enzymes used to generate the Drosophila
pUB Cherry vector.

Ubi63E = ubiquitin 63 E promoter region, PizMCS = pIZ

vector multiple cloning site.
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this vector using the primers listed in Table 4. A schematic of the human and
Drosophila clones is shown in Figure 8.

Generation of GFP hIntS7 Deletion Mutants
Nine N-terminal and nine C-terminal deletion mutants of hIntS7 were
generated for this project. Primers were made at approximately 100 amino acid
intervals from the N and C-terminal ends of hIntS7 to generate a series of
fragments, NΔ1-9 and CΔ1-9 (Table 5). The reverse primer used to clone fulllength hIntS7 in the fluorescent-tagged clones above was used to make the Nterminal deletion fragments, and the forward primer was used to make the Cterminal deletion fragments (Table 4). These fragments were then cloned into the
N-terminal GFP vector using EcoRI and XbaI restriction sites (Figure 9).

Cell Fixation and Immunofluorescence
Human cells
HeLa cells were plated at 2.5×105 cells/well in 6-well plates containing cover
slips (Fisher Scientific, Pittsburg, PA) coated with a 50µg/mL poly-D-lysine solution
(Sigma-Aldrich, St. Louis, MO). To coat the cover slips, the poly-D-lysine solution is
pipetted onto the cover slips and allowed to sit for one hour. The solution is then
aspirated and the cover slips are dried completely.

For detection of tagged

Integrator proteins, the cells were transfected with 100-500ng of plasmid DNA and
incubated for 24 hours before fixation.
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For cells transfected with fluorescently

tagged proteins, the cells were washed with phosphate buffered saline (PBS) then
fixed in 4% paraformaldehyde (PFM; Electron Microscopy Sciences, Hatfield, PA)
for 10 minutes. The cells were then washed with PBS and the nucleus was stained
with a 1:10,000 solution of DAPI in PBS for 10 minutes at 37°C.

After DAPI

staining, the cells were washed twice with PBS and then mounted onto glass
microscope slides using an anti-fade mounting medium (Electron Microscopy
Sciences).
In cells that were probed for endogenous proteins, the cells were first
washed and fixed in the same manner as above. After fixing, the cells were washed
once with PBS, and permeablized with 0.5% triton X-100 in PBS for 5 minutes. The
cells were then washed three times with copious amounts of PBS. After this, the
cells were blocked with a 10% normal goat serum (NGS; Sigma-Aldrich) solution in
PBS for 30 minutes at 37°C. Primary antibodies, mouse α-coilin (obtained from the
Matera Laboratory) and rabbit α-hIntS3 and α-hIntS7 (gift from Proteintech Group,
Chicago, IL) were then added at a 1:1000 dilution and the cells incubated for
another 30 minutes. The cells were washed with PBS twice for five minutes at room
temperature while rotating and then the fluorescently conjugated secondary
antibody (α-mouse and α-rabbit AlexaFluor 555 and α-rabbit AlexaFluor 647 from
Invitrogen) was added at 1:1000 for 30 minutes at 37°C.

The cells were then

washed with PBS twice for five minutes while rotating. DAPI staining and mounting
were carried out as stated above.
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Table 4: Primer sets and restriction enzymes used to generate mCherry
tagged Drosophila Integrator subunit clones. All Drosophila clones have the
mCherry tag placed on the N-terminus of the Integrator subunit.
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Primer
Sets

Primer Sequence
(5’-3’)

dIntS2 F
dIntS2 R

GGCCGGATCCAATGCCGGTGAGGATGTACGATGTATCG
GGCCTCTAGACTAATACAGGTCCGATTTTTTCATGACCGCC

BamHI
XbaI

dIntS3 F
dIntS3 R

GGCCGGATCCAATGGAACAGCAGCAATCAAAAAATAATGCT
GGCCGCGGCCGCTCAGTCAGAATCATTGTTAGCTTTTTTCC

BamHI
NotI

dIntS5 F
dIntS5 R

GGCCGGATCCAATGCTGCGCCAGAACCTGTTGGATCAGCTTAAG
GGCCTCTAGATTAATCTATTTCAACGATCTGCAGCCGGGCC

BamHI
XbaI

dIntS6 F
dIntS6 R

GGCCACTAGTCATGACAATCATACTCTTCCTGGTGG
GGCCCTCGAGTTAACTCTTGGCGACGGCCTGCTCCG

SpeI
XhoI

dIntS7 F
dIntS7 R

GGCCACTAGTCATGTCTCACCTGACCGGCACCCGCGTG
GGCCCTCGAGTTAAAACCTCCTCGTCTGTCCCACTG

SpeI
XhoI

dIntS9 F
dIntS9 R

GGCCGGATCCAATGCGATTGTATTGTCTCAGCGGGGACC
GGCCTCTAGATTAAAAACTCTGTAAGCATTTCATGATGGTGTCTC

BamHI
XbaI

dIntS10 F
dIntS10 R

GGCCGGATCCAATGCCGAGCCAAGAGGAAAATGAGTTGTACATG
GGCCTCTAGATCACTTAATCACAATCGTCTCCACGGGCTGAC

BamHI
XbaI

dIntS12 F
dIntS12 R

GGCCACTAGTCATGGCCGCAAATATAGCCGCC
GGCCTCTAGATTACTGCTTGGATCTGCGCTT

SpeI
XbaI

dIntS13 F
dIntS13 R
(ASU)

GGCCGAATTCATGTTCGAACGCAACCAGAAG
GGCCCTCGAGTTAACTACGTACGGATTC

EcoRI
XhoI

dIntS14 F
dIntS14 R
(CG4785)

GGCCGAATTCATGCCCACCTTAATAGCGCTG
GGCCCTCGAGTCAATACATGTATGCAGGAGC

EcoRI
XhoI
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Restriction
Sites

Figure 8: Schematic of Drosophila and human tagged Integrator Clones. The
Drosophila clones contain mCherry N-terminal to the Integrator subunits, while
human vectors were crated so that mCherry and GFP could be placed both Nterminal and C-terminal to the Integrator subunits.
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Table 5: Primers and restriction enzymes used to generate human IntS7
deletion fragments. The NΔ primers are forward primers with an EcoRI restriction
site, and the hIntS7 full-length reverse primer with a stop codon in Table 2 was used
with these primers. The CΔ primers are reverse primers with an XbaI restriction
site, and the hIntS7 full-length forward primer in Table 2 was used with these
primers.
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Deletion

Primer Sequence
(5’-3’)

NΔ1

GGCCGAATTCTGTGGATGAATTTGTGAAGAGA

NΔ2

GGCCGAATTCTGATGCAATCTTGGCTTCCAGT

NΔ3

GGCCGAATTCTTTGTCTGTCCTTTCCACACTA

NΔ4

GGCCGAATTCTTTAAAGATTGCTCTAAACTGT

NΔ5

GGCCGAATTCTGTGATTGGACGATCAGCCACA

NΔ6

GGCCGAATTCTTCAGCACTTTCTTGCATTGCT

NΔ7

GGCCGAATTCTAAACAGTCCATGGAAGAATTT

NΔ8

GGCCGAATTCTTATATGCACACAGCATGCCTC

NΔ9

GGCCGAATTCTCAAAGGGTTGAACCTCATAAT

CΔ1

GGCCTCTAGATTACTCCATCTCATTGGTCATGTT

CΔ2

GGCCTCTAGATTAAGAAACAGGGGTATATTTCCG

CΔ3

GGCCTCTAGATTACATCTGATTGGAGATGCGACC

CΔ4

GGCCTCTAGATTAACTATAATTTTCCTCTTGCAA

CΔ5

GGCCTCTAGATTACTTGTACAGCTCCATGAGGTC

CΔ6

GGCCTCTAGATTAAGTGGCCTGAGCACCTGGACT

CΔ7

GGCCTCTAGATTACATCCCTAGTTTTAAGCTGTC

CΔ8

GGCCTCTAGATTAATGGTGCATGTGCTGTAGAAT

CΔ9

GGCCTCTAGATTAATTTAGAATCTTCTCCAAATG
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Figure 9: Schematic of hIntS7 deletion mutants. Removing amino acids from
each end in approximately 100 amino acid intervals created nine N-terminal and
nine C-terminal deletion mutants. All deletion mutants were cloned into the pcDNA4
N-terminal GFP vector.
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Drosophila Cells
Drosophila S2 cells were plated at 106 cells/well in 24-well plates, transfected
with 800ng of plasmid DNA and incubated for 24-48 hours. Cover slips (Fisher
Scientific) were placed in a new 24-well plate and coated with a 50µg/mL
concanavalin A (Sigma-Aldrich) solution. The transfected S2 cells were diluted 1:61:10,replated into new wells, and allowed to adhere to the concanavalin A cover
slips for two hours. Concanavalin A causes the S2 cells to spread on the cover slip
were they would usually loosely attach. The media was then removed and the cells
were washed with PBS. The cells were fixed with 10% PFM for 10 minutes at room
temperature and washed again with PBS. A 1:5000 DAPI in PBS solution was
added and the cells were incubated at room temperature for 10 minutes to stain the
nucleus. In my hands, increasing the concentration of DAPI and the time of
incubation resulted in optimal DNA signal. Finally the cells were washed twice with
PBS and mounted in the same way as the human cells.
All slides were visualized using the Nikon A1R Confocal Laser Microscope
System in the Cytodynamic Imaging Facility in the Department of Integrative Biology
and Pharmacology at the UT Medical School. All images were taken using a 60X
plan-Apo/1.4 NA Oil objective. Images were processed using Adobe Photoshop.

RNAi
Human siRNA sequences against hIntS7, 5’ GGCUAAAUAGUUUGAAGGA
3’ and 5’ CUCUAAACUGUAUGGUGAA 3’ were purchased from Sigma-Aldrich. To
perform siRNA knockdown experiments, HeLa cells were plated at 1.2×105
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cells/well in a 24-well plate.

24 hours later, the siRNA was transfected using

Lipofectamine 2000. Briefly, 3µL/well of siRNA and 47µL/well of Opti-MEM medium
were mixed in tube A, and 3µL/well Lipofectamine 2000 and 12µL/well Opti-MEM
were mixed in tube B and incubated for seven minutes at room temperature. The
tube were then combined and incubated for 25 minutes at room temperature. After
this incubation, 38µL/well of Opti-MEM was added to the transfection solution, and
100µL was added to each well.
To generate double stranded (dsRNA) for RNAi in Drosophila S2 cells, first, forward
and reverse T7 primers with the sequence 5’-GGTAATACGACTCACTATAG-3’ plus
18-30 nucleotides of gene specific sequence were designed for dIntS1-14 and
Thread (positive control) at the positions shown in Figure 10. The T7 templates
were amplified using PCR, and the resulting DNA was subjected to phenolchloroform purification and ethanol precipitation for 15 minutes at -20°C and then
resuspended in dH20 at approximately 1µg/µL. These templates were then used to
generate dsRNA via in vitro transcription. To set up the 300µL in vitro transcription
reaction, 9µL of 62.5 mM NTPs, 30µL 10X transcription buffer (400mM Tris (pH8),
150mM MgCl2, 50mM DTT, 0.5 mg/mL BSA), 10µL DNA template, 1-10µL T7 RNA
polymerase and 250µL dH20 were mixed together. This was then incubated at
37°C for 24 hours. 1µL of DNaseI was then added and the reaction incubated for
30 minutes at 37°C. After this, the reaction tubes were placed in a beaker of water
and brought to a boil. The reaction was boiled for 2 minutes and then cooled to
room temperature in the water. Once cooled, 1µL of the dsRNA was run on a 1%
agarose gel with a dsRNA ladder to quantify; the top band of 2µL of the dsRNA
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Figure 10: Positions of Drosophila dsRNA sequences. Forward and reverse T7
primers were designed to the positions shown to generate dsRNA for use in S2
knockdown experiments. Each dsRNA sequence is approximately 500 base pairs.
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ladder (New England Biolabs, Ipswich, MA) equals 140ng dsRNA. To perform RNAi
knockdown in S2 cells; cells are resuspended at 106 cells/mL and 70µL of this
suspension is plated in 96 well plates. The cells are then treated with 10µg/mL
dsRNA for three days and then collected.

Western Blot
Cells were collected and lysed for Western blot by incubating them 50250µL of low-salt lysis buffer for one hour. Relative protein levels were determined
using the Bradford assay, and all samples were normalized to the lysate containing
the least protein. To prepare the lysates for gel electrophoresis, up to 20µL of each
lysate was mixed with an equal amount of 2X SDS loading buffer and boiled for five
minutes at 95°C. The boiled samples and protein ladder (Fermentas) were loaded
into a 12.5% SDS polyacrylamide gel. The samples were run at 80V through the
stacking gel, and then the voltage was increased to 150V and the samples were run
until the dye front ran off the bottom of the gel. The proteins were transferred to a
PVDF membrane overnight at 30V. The membrane was blocked for one hour in 5%
milk then probed with the primary antibody in 5% milk for one hour. The primary
antibody used in this project was the mouse α-GFP antibody, JL-8 (Clontech,
Mountain View, CA) used at 1:5000. The membrane was then washed three times
for 10 minutes with 5% milk.

Next, the membrane was probed with α-mouse

horseradish peroxidase conjugated secondary antibody (Invitrogen) at 1:5000 in 5%
milk for one hour, and this was followed with another set of washes. After the final
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wash, the milk is rinsed off of the membrane with PBS, and the membrane is
incubated for five minutes in ECL solution (Thermo Scientific, components mixed
1:1) then placed in an autoradiography cassette. Film is exposed to the membrane
for <30 seconds to 10 minutes then developed.
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Chapter 3:
Results
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The Localization of Integrator Subunits.
With the exception of IntS9 and 11, which serve as the cleavage factor for
snRNA processing, little is known about the functions of the other Integrator
subunits. Determining the subnuclear localizations of these subunits could provide
valuable clues as to the function of the Integrator subunits, therefore, mCherry and
GFP tagged clones were generated for all the human and Drosophila Integrator
subunits with the exception of hIntS1 and 8 as well as the human orthologues of
Drosophila Asunder (Asu, IntS13) and CG4785 (IntS14) as cDNAs were not
available at the time of this project. In addition, dIntS1, 4, 6, 8, 10, and 11 which
could not be cloned in the timeframe of this project.
To generate the expression vectors for the human Integrator subunits,
mCherry and GFP cDNAs were cloned into the pcDNA4/TO/Myc-His A vector to
create the four expression vectors: N-terminal GFP, C-terminal GFP, N-terminal
mCherry, and C-terminal mCherry. The rationale for creating these four constructs
were to test and compare localization of Integrator proteins by tagging both at the
N-terminus and C-terminus to address any tag positional effects. Also, we used two
fluorescence tags to address any potential artifacts associated with these fusion
proteins. The Integrator subunits were then cloned into these vectors to generate
Integrators that were tagged both N-terminally and C-terminally with GFP and
mCherry. 500ng/well of these plasmids were transfected into HeLa cells plated on
poly-D-lysine coated cover slips, which were subsequently fixed and imaged using
confocal microscopy. The majority of the human Integrators, hIntS4, 5, 6, 9, 10, 11,
and 12 display no remarkable subcellular localization. They are diffusely nuclear,
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which we predicted given their role in snRNA 3’ end processing, a nuclear event.
However, while still nuclear, hIntS3 was observed in discrete foci, and surprisingly,
hIntS2 and 7 were observed to form discrete cytoplasmic foci with little expression
seen in the nucleus (Figure 11).
Tagged clones of Drosophila Integrator proteins were also created for
transfection in S2 cells. cDNAs for the Drosophila Integrator subunits were cloned
into the pUB Cherry expression vector constructed for this purpose by cloning the
ubiquitin 63E promoter, pIZT/V5-His vector MCS and mCherry cDNA into the
pUC19 vector. This resulted in plasmids with mCherry N-terminal to the Integrator
subunits. 800ng/well of these plasmids were transfected into S2 cells, and these
cells were transferred 24-48 hours later onto concanavalin A coated cover slips,
fixed and imaged using confocal microscopy.

Localizations for the Drosophila

Integrator subunits are shown in Figure 12. dIntS5, 6, 9, and 12 as well as Asu
(dIntS13) and CG4785 (dIntS14) demonstrate diffuse nuclear localization as was
expected for most subunits, and dIntS2 and 7 localized to discrete cytoplasmic foci,
similar to hIntS2 and 7 in HeLa cells. The nuclear foci seen with hIntS3 in HeLa
cells were not observed with dIntS3 in S2 cells; rather, dIntS3 seems to be diffusely
spread throughout the cell, suggesting Drosophila IntS3 does not share a similar
localization with human IntS3. However, S2 cells did not tolerate overexpression of
proteins well, and it is possible that the tagged form of dIntS3 does not localize to
nuclear foci, but the endogenous protein does.
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Figure 11: Confocal images of human Integrator subunit localizations. Most of
the human Integrator subunits exhibit a diffuse nuclear localization. The exceptions
are hIntS2, 3, and 7. hIntS3 forms distinct foci in the nucleus, while hIntS2 and 7
form distinct cytoplasmic foci (arrows). Some of the images show N-terminal GFP
tagged Integrators and C-terminal mCherry tagged Integrators to demonstrate that
the localizations of these tagged proteins overlap and the tags or their location on
the protein are not the cause of the shown localizations. Cells transfected with a
single tagged construct yielded similar results.
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Figure 12: Confocal images of Drosophila Integrator subunit localizations.
Most of the Drosophila Integrator subunits display diffuse nuclear localization,
however dIntS2 and 7 display discrete cytoplasmic foci (arrows).
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Human IntS3 Colocalizes with Cajal Body Marker Coilin in the Nucleus.
Given the localization of hIntS3 to nuclear foci we hypothesized that hIntS3
could be associating with a known nuclear body such as histone locus bodies,
nuclear speckles, or Cajal bodies.

Histone locus bodies form at the genes of

replication dependent histones and contain biomolecules such as the U7 snRNP
and other factors necessary for the 3’ end processing of histone mRNA [65].
Nuclear speckles are sites of U snRNP maturation and storage; [66] while Cajal
bodies are often observed adjacent to snRNA genes and are sites of snRNA
transcription that have also been shown to monitor the export of snRNAs from the
nucleus [71]. Since the Integrator complex is involved in snRNA transcription and 3’
end processing, we hypothesized that hIntS3 localizes to the Cajal bodies.
Colocalization studies were carried out with coilin, a standard Cajal body
marker to determine if our hypothesis was accurate. First, HeLa cells transfected
with GFP-hIntS3 were stained for endogenous coilin (Figure 13, top panel). The
GFP-hIntS3 foci colocalized completely with the coilin foci, implying that hIntS3
does localize to Cajal bodies in the nucleus. Colocalization studies staining both
endogenous hIntS3 and coilin were also performed to confirm the localization of
hIntS3 to Cajal bodies (Figure 13, bottom panel).

Endogenous hIntS3 forms

nuclear foci as well, and these foci completely colocalize with coilin foci,
corroborating the results seen with GFP-tagged hIntS3. These results confirm our
hypothesis that hIntS3 localizes to the Cajal bodies.
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Figure 13: hIntS3 colocalizes with coilin.

Both the exogenous GFP tagged

hIntS3 (top panel) protein and the endogenous hIntS3 protein (bottom panel)
colocalize with the Cajal body protein coilin. AF – AlexaFluor 555 (red) and 647
(green) were used to stain endogenous proteins.
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Human and Drosophila IntS2 and 7 Colocalize with P Body Marker Dcp1 in
Discrete Cytoplasmic Foci.
The most interesting and unexpected finding of this project was the
localization of IntS2 and 7 to cytoplasmic foci, and as a result, these two subunits
became my focus. As with hIntS3 in the nucleus, there were several cytoplasmic
bodies considered to be possible locations for IntS2 and 7 in Drosophila and human
cells, including stress granules, U bodies, and P bodies. Stress granules are sites
where mRNPs stalled in translation initiation aggregate along with initiation factors,
the 40S ribosomal subunit, and Pab1 [97].

U bodies are cytoplasmic foci that

contain all the U snRNPs in addition to snRNP assembly factors such as SMN, and
are hypothesized to be sites of U snRNP assembly [100]. Finally, P bodies are
sites of storage for translationally repressed mRNPs as well as sites of mRNA
decapping and decay and miRNA and siRNA gene silencing [93].
While stress granules and P bodies are both mRNA granules, U bodies are
predicted to play a role in U snRNP assembly and were first thought to be a likely
localization for cytoplasmic Integrator subunits.

However, colocalization studies

with hIntS7 and SMN performed by our collaborator, Mirek Dundr from Rosalind
Franklin University in Chicago, Illinois showed that the two proteins do not
colocalize (personal communication), therefore it is unlikely that IntS2 and 7 localize
to U bodies. We therefore predicted IntS2 and 7 localize to P bodies because
stress granules consist solely of translationally stalled mRNPs and the Integrator
complex has not been implicated in translation. Additionally, it is possible that these
Integrator subunits may play a role in the decay of U snRNAs.
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To determine if IntS2 and 7 localize to P bodies colocalization studies with P
body marker Dcp1 were performed. HeLa cells were co-transfected with 500ng of
Cherry-hIntS2 or 7 and 500ng GFP-Dcp1 (plasmid obtained from the Shyu
Laboratory) then fixed and imaged (Figure 14).

hIntS2 and 7 foci colocalized

completely with Dcp1 foci, tentatively confirming our hypothesis.

Endogenous

hIntS7 was also stained in HeLa cells (Figure 15, top panel) and this result
confirmed the presence of hIntS7 in cytoplasmic foci. Endogenous hIntS7 was also
stained in HeLa cells transfected with GFP-Dcp1 and the hIntS7 foci again
colocalized with the GFP-Dcp1 foci (Figure 15, bottom panel), further demonstrating
the presence of hIntS7 in P bodies. Colocalization of Drosophila IntS2 and 7 and
Dcp1 was also performed in S2 cells co-transfected with 800ng of Cherry-dIntS2 or
7 and 800ng of Drosophila GFP-Dcp1 (plasmid cloned by Jiandong Chen while
rotating in the Shyu laboratory) and these two subunits were also shown to
colocalize with Dcp1 in this model as well (Figure 16).

IntS1 and 11 Are Required for IntS2 and 7 Localization to Cytoplasmic Foci in
Drosophila S2 Cells.
Here, I addressed the question of the dependency of IntS2 and IntS7
cytoplasmic foci on expression of other Integrator subunits. The interdependency of
dIntS2 and 7 on the expression of the other Integrator subunits was explored
through systematically knocking down each Integrator subunit and monitoring the
effects on the localization of dIntS2 and 7 in S2 cells. On day one, S2 cells were
plated in a 96-well plate and treated with dsRNA to the 14 Integrator subunits as
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Figure 14: Cherry hIntS2 and 7 colocalize with GFP Dcp1.

Both mCherry

tagged hIntS2 and 7 colocalize with GFP tagged P body marker Dcp1.
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Figure 15: Endogenous hIntS7 localization.

Endogenous hIntS7 localizes to

discrete cytoplasmic foci (top panel) and these foci colocalize with GFP tagged
Dcp1 (bottom panel). AF – AlexaFluor 555 was used to stain endogenous protein.
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Figure 16: Cherry dIntS2 and 7 colocalize with GFP Dcp1. mCherry tagged
dIntS2 and 7 colocalize with GFP tagged P body marker Dcp1 (arrows).
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well as Thread, which was used as a positive control. On day two, the cells were
transfected with 500ng/well of either Cherry-dIntS2 or 7, and on day three the cells
were treated a second time with dsRNA. Finally, on day four the cells were fixed
and visualized using confocal microscopy.

It was found that the same two

Integrator subunits, dIntS1 and 11 disrupted the localization of both dIntS2 and 7.
When dIntS1 was knocked down dIntS2 was no longer expressed while dIntS11
knockdown cause dIntS2 to localize diffusely in the nucleus. dIntS7 was found to
be either diffusely in the nucleus or diffusely in the cytoplasm when dIntS1 was
knocked down, and knockdown of dIntS11 led to a diffuse cytoplasmic localization
for dIntS7. These results are summarized in Table 6 and representative images for
dIntS7 are shown in Figure 17.
The experiment was then repeated in cells transfected with Cherry dIntS2 or
7 or GFP-Dcp1, this time knocking down only dIntS1, 11, and 12. Knocking down
IntS12 served as a negative control as we did not see any disruption in localization
in the previous set of experiments. This experiment was performed in triplicate and
the results quantified. As expected, when dIntS12 was knocked down, no change
was observed in the localization of dIntS2 or 7 (Figure 18). When dIntS1 was
knocked down Cherry-dIntS2 was localized to discrete foci in 56 ± 4% of cells. It
was diffusely cytoplasmic in 36 ± 4% of cells and diffusely cytoplasmic in 8 ± 4% of
cells. Cherry-dIntS7 was localized to discrete foci in 47 ± 11% of cells, diffusely
cytoplasmic in 51 ± 12% of cells and diffusely nuclear in 1 ± 1% of cells (Figure 19).
Cherry-dIntS2 was localized to discrete foci in 81 ± 3% of cells in which dIntS11
was knocked down, diffusely cytoplasmic in 12 ± 3% of cells and diffusely nuclear in
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Table 6: Summary of Integrator subunit knockdown experiment. The effects of
Integrator subunit knockdown on the localization of dIntS2 and 7 are listed. * dIntS2
is diffuse in the nucleus, # dIntS7 is diffuse in the nucleus or cytoplasm, ⌘ dIntS7 is
diffuse in the cytoplasm.
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Figure 17: Effects of Integrator subunit knockdown on dIntS7 localization.
The localization of dIntS7 exhibits no dependence on the expression of the majority
of the other Integrator subunits (dIntS5 knockdown shown).

However, the

knockdown of dIntS1 produces dIntS7 localization that is either diffusely nuclear or
cytoplasmic, and the knockdown of dIntS11 yields diffusely cytoplasmic dIntS7
localization.
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Figure 18: Quantification of the effects of dIntS12 knockdown on dIntS2 and 7
localization. A. When dIntS12 is knocked down, no change in mCherry dIntS2 and
dIntS7 and GFP Dcp1 was observed. B. Representative images of localizations
observed.
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Figure 19: Quantification of the effects of dIntS1 knockdown on dIntS2 and 7
localization.

A. When dIntS1 is knocked down, mCherry dIntS2 localized to

discrete cytoplasmic foci in 56 ± 4% of cells, was diffusely cytoplasmic in 36 ± 4% of
cells and was diffusely nuclear in 8 ± 4% of cells. mCherry dIntS7 localized to
discrete foci in 47 ± 11% of cells, was diffusely cytoplasmic in 51 ± 12% of cells and
diffusely nuclear in 1 ± 1% of cells. There was no change in the localization of GFP
tagged Dcp1. B., C., D. Representative images of localizations observed.
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7 ± 2% of cells. Cherry-dIntS7 was in discrete foci in 80 ± 1% of cells, diffusely
cytoplasmic in 15 ± 2% of cells and diffusely nuclear in 5 ± 1% of cells (Figure 20).
Additionally, no change was observed in the localization of GFP-Dcp1 when any of
the Integrator subunits were knocked down.

Deletions in Human IntS7 Gene Have Little Effect on hIntS7 Localization.
The amino acid alignment of IntS7 shown in Figure 21 highlights two
conserved regions in the IntS7 protein. The first one (red box) corresponds to the
ARM repeats which function in protein-protein interactions found in approximately
the first 200 amino acids, and the second (blue box) is the DUF 3453, which is also
found in Symplekin.

To determine if these domains are responsible for the

localization of hIntS7 to cytoplasmic foci a series of deletion mutants were created
and their localizations were compared to that of the full-length hIntS7. Nine Nterminal and nine C-terminal deletion mutants were generated in the GFP-N vector
(expression shown in Figure 22 C.) and these were co-transfected into HeLa cells
with Cherry-hIntS7 and imaged using confocal microscopy. 500ng/well of CherrhIntS7 was transfected, however the amount of deletion mutant plasmid was
adjusted to ensure even expression. Deletion of any part of the protein led to
stronger nuclear staining where none was observed in cells transfected with the fulllength protein.

This localization, however, was not accompanied by a loss of

discrete cytoplasmic foci (Figure 22 A. and B.).

Depletion of Human IntS7 Leads to Increased snRNA Misprocessing.
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Figure 20: Quantification of the effects of dIntS11 knockdown on dIntS2 and 7
localization. A. When dIntS11 is knocked down, mCherry dIntS2 localized to
discrete cytoplasmic foci in 81 ± 3% of cells, was diffusely cytoplasmic in 12 ± 3% of
cells and was diffusely nuclear in 7 ± 2% of cells. mCherry dIntS7 localized to
discrete foci in 80 ± 1% of cells, was diffusely cytoplasmic in 15 ± 1% of cells and
diffusely nuclear in 5 ± 1% of cells. There was no change in the localization of GFP
tagged Dcp1. B., C., D. Representative images of localizations observed.
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Figure 21: Six species alignment of IntS7.

An alignment of the amino acid

sequence of IntS7 for six species, human, cow, chicken, Xenopus, zebrafish, and
Drosophila reveal two areas of high sequence similarity.

The first (red box)

corresponds to the ARM repeats in the first ≈200 amino acids. The second (blue
box) corresponds to the DUF 3453.
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Figure 22: GFP tagged hIntS7 deletion mutant localizations. Deletion of any
part of hIntS7 leads to stronger nuclear staining, however, discrete cytoplasmic foci
are still detectable. A. N-terminal deletions, B. C-terminal deletions, C. Western blot
showing expression of deletion fragments.
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B.
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C.
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While human and Drosophila IntS2 and 7 display a cytoplasmic localization,
it has been shown in S2 cells that depletion of these subunits leads to accumulation
of misprocessed snRNAs, suggesting that IntS2 and 7 also play a role in the
nucleus [38]. A humanized version of the GFP-U7 snRNA reporter used in [38] was
developed to determine if depletion of hIntS7 effects snRNA processing in HeLa
cells. Two hIntS7 siRNA sequences were used in this experiment as well as a
control siRNA sequence and the experiment was done in triplicate. Briefly, cells
were plated in 24-well plates and allowed to attach overnight. Then, the cells were
treated with siRNA once and again a second time 24 hours later. 24 hours after the
last siRNA treatment, the cells were transfected with the GFP-U7 reporter plasmid
and mCherry plasmid. The next day the amount of GFP and mCherry fluorescence
was measured in multiple locations in each well and the results quantified. mCherry
expression was used as a control readout and GFP expression was normalized to
the amount of mCherry expression. The normalized GFP expression of the test
siRNA wells was then normalized to the control siRNA wells to derive the fold
increase in GFP expression in hIntS7 depleted cells (Figure 23). A 26 ± 6 fold
increase in GFP expression was seen in cells treated with hIntS7 siRNA 7-1 and a
13 ± 2 fold increase in GFP expression was seen in cells treated with the 7-2
siRNA.

From these results, we concluded that depletion of hIntS7 leads to

increased misprocessing of snRNAs in human cells as well as Drosophila cells.
These data also suggest that IntS7 is required for the processing occurring in
nucleus and likely resides there as well as the cytoplasm. Additionally, in cells
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Figure 23: Depletion of hIntS7 leads to misprocessing of snRNA in human
cells. Misprocessing of snRNA in HeLa cells increases 25.84 ± 5.93 fold over
control cells (C2) when hIntS7 is knocked down with siRNA 7-1 and 13.06 ± 1.51
fold when knocked down with siRNA 7-2 (graph). Bottom panel shows examples
expression of hU7-GFP reporter and mCherry for each case.
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stained for endogenous hIntS7, staining can be observed in the nucleus along with
the cytoplasmic foci, further confirming this conclusion (Figure 15).
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Chapter 4:
Conclusion and
Future Directions
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The purpose of this study was to paint a picture of Integrator subunit
localization in the cell. Between the human and Drosophila models, localizations for
all of the subunits, with the exception of IntS1 and 8 were revealed, and
localizations seen in one model generally held for the other. From these images we
conclude that the majority of the Integrators are diffusely spread across the nucleus,
an expected result given the major function of the Integrator complex is to facilitate
the proper 3’ end processing of snRNAs. We also hypothesized that some of the
subunits would localize to discrete subnuclear domains such as Cajal bodies, which
are found adjacent to snRNA genes and are sites of snRNA transcription [50].
Confirming this, hIntS3 was seen in discrete nuclear foci that colocalized with Cajal
body marker coilin.

Unexpectedly, however, IntS2 and 7, in both human and

Drosophila cells was observed in discrete cytoplasmic foci, a localization
incompatible with the known nuclear function of the Integrator complex. These foci
colocalized with Dcp1 suggesting that these subunits are present in P bodies.

The Localization of IntS3 in Cajal Bodies.
The colocalization of endogenous hIntS3 and coilin confirms the presence of
hIntS3 in Cajal bodies, however, further biochemical experiments, such as
immunoprecipitation (IP) of IntS3 and coilin as well as IP/mass spectrometry (MS)
of Cajal body components would provide additional support for this conclusion [37].
While the role of IntS3 in Cajal bodies is unknown, it might function to recruit Cajal
bodies and/or other Integrators to snRNA genes. Interestingly, it has been shown
that depletion of IntS3 in S2 cells has no effect on snRNA processing [38]. These
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data suggest that while IntS3 might facilitate the recruitment of these factors to
snRNA genes, processing of snRNAs is not compromised when IntS3 is depleted.
The role of IntS3 in snRNA processing in human cells has not been formally tested
and thus it may behave differently in human cells playing a more dominant role in
processing. One alternative hypothesis is that IntS3 is indeed required for
processing of snRNA but it may also be required for transcription of snRNA.
Therefore, depletion of IntS3, unlike other Integrator subunits, would not result in
accumulation of misprocessed snRNA but rather a depletion of processed only. It
would be interesting to determine if cells in which IntS3 is depleted produce less
snRNA than cells with functioning IntS3.

Additionally, it would be useful to

determine the fate of Cajal bodies when IntS3 is depleted. If IntS3 is responsible for
the recruitment of Cajal bodies to snRNA genes, depletion of IntS3 could prevent
the localization of Cajal bodies to these sites or possibly prevent the formation of
Cajal bodies all together.

Integrators 2 and 7 Display a Conserved Phenotype of P Body Localization.
Here, we show that mCherry tagged IntS2 and 7 colocalize with GFP tagged
Dcp1 in both HeLa and S2 cells. This finding was further confirmed through the
detection of endogenous hIntS7 in P bodies. As with IntS3, further studies should
be completed to confirm the presence of IntS2 and 7 in P bodies that are
biochemical in nature. These include IP of IntS2/7 with Dcp1 and IP/MS of P body
components as mentioned previously.
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P bodies have been shown to be dynamic structures with molecules such as
Dcp1 constantly entering and leaving [93]. This was determined using a technique
called fluorescence recovery after photobleaching (FRAP) where a particular region
is photobleached using a confocal microscope and the rate of the return of
fluorescent molecules that that region is monitored. This experimental technique
has been mastered by the Dundr laboratory at Rosalind Franklin University and was
performed with our tagged Integrator constructs by Dr. Mirek Dundr. To determine
if hIntS7 displays a dynamic association with P bodies similar to Dcp1 a similar
technique called inverse (iFRAP) was used whereby the area surrounding a
particular region is photobleached and the rate that the fluorescent molecules leave
that region is monitored. Cells were transfected with Cherry-hIntS7 and GFP-Dcp1,
and iFRAP was performed on several hIntS7 and GFP foci. We predicted that the
association of hIntS7 with the cytoplasmic foci would be dynamic with hIntS7
proteins slowly migrating away from the targeted foci, similar to what is seen with
Dcp1 foci. However, this was not the case. While the Dcp1 foci were dynamic in
this experiment, hIntS7 was very stable in the foci with very little protein moving
away (Figure 24).
Although IntS2 and 7 appear to colocalize with Dcp1 in P bodies, the
Integrator subunits behave differently in these structures than Dcp1 evidenced by
the results of the iFRAP experiment described above, which demonstrates that
hIntS7 is more stable within its foci while Dcp1 is more dynamic. Testing the effects
of drugs, such as, cycloheximide and RNase A, which have been shown to disrupt
the formation of P bodies in cells, on IntS2 and 7 foci as well as the effects of
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Figure 24: Inverse FRAP of mCherry hIntS7 and GFP Dcp1.

The Y-axis

represents the percentage of original fluorescence immediately after iFRAP. The
percentage decreases over time as the GFP or mCherry-fusion protein diffuses out
of the foci. The X-axis is a timescale of the experiment in seconds.
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depletion of Dcp1 or other P body components would provide further insight to the
behavior of these proteins in the cytoplasm.
The localization of these two proteins in P bodies was not expected. Aside from
these structures residing in the cytoplasm where snRNA processing does not occur,
P bodies contain many factors involved in mRNA destabilization or translational
repression. Thus, it is not clear what the function of Integrator subunits would be
while in P bodies.

It is possible that they have a distinct cytoplasmic-specific

function that is somehow relevant to mRNA decay. Alternatively, one function that
fits nicely with P body localization is snRNA decay. While IntS2 and 7 do not seem
to play a role in the decay of misprocessed snRNA, it is possible that they target
snRNAs not properly assembled into snRNPs for decay in P bodies.

One

hypothesis is that IntS2 and 7 remain associated with the snRNA after it is cleaved
and exported to the cytoplasm. Once in the cytoplasm, IntS2 and 7 monitor the
assembly of the snRNP, and shuttles misassembled snRNP to P bodies for decay.
Blocking nuclear export with leptomycin B, for example, would be one way to test
this hypothesis, however, the iFRAP study suggests against the shuttling of IntS7
between the nucleus and the cytoplasm. It is still possible that these Integrators
play a role in the decay of misassembled snRNPs or snRNAs exported to the
cytoplasm, but not assembled into snRNPs. To investigate this theory, SMN or one
of the Sm proteins could be knocked down via RNAi and the size of the IntS2 and 7
foci could be monitored. Larger foci would suggest that IntS2 and 7 are shuttling
snRNAs unable to be assembled into snRNP to the P bodies for decay.
Additionally, in situ hybridization could be used to determine if snRNAs can be
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detected in P bodies. It is also possible that IntS2 and 7 in P bodies function in a
role that is completely separate from snRNA 3’ end processing and decay.
While it is unknown if the disruption of Dcp1 or other P body components
affects the expression of IntS2 and 7 in cytoplasmic foci, the depletion of Ints1 and
11 in Drosophila S2 cells appears to reduce the number of cells with IntS2 or 7 foci.
IntS11 is the catalytic subunit of the Integrator complex, responsible for the 3’
cleavage of the nascent snRNA. Its depletion produces misprocessed snRNA in
the cell [38] suggesting that properly processed snRNA is necessary for the
localization of IntS2 and 7 to cytoplasmic foci.

IntS1 causes abundant

misprocessing when depleted as well, supporting this hypothesis. However, the
depletion of other Integrator subunits, which also cause misprocessing when
disrupted, had no effect on the localization of IntS2 and 7. This discrepancy implies
the disruption of the localization of IntS2 and 7 through the depletion of IntS1 and
11 could be unrelated to the 3’ end processing of snRNA and these four Integrator
subunits form a sub complex that performs an entirely different function.

Domain Analysis of IntS7 with Respect to Its Cellular Localization.
In this study we attempted to define the domain responsible for the
localization of Ints7 to cytoplasmic foci by designing GFP tagged deletion mutants
of hIntS7. We hypothesized that the highly conserved ARM repeat region at the Nterminus of the protein may be involved in the aggregation of the protein in
cytoplasmic foci considering ARM repeats function in protein-protein interactions.
However, this was not the case, as cytoplasmic foci could still be detected in
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mutants in which this region was deleted.

In fact, cytoplasmic foci could be

observed in all deletion mutants made, and we were unable to pinpoint an exact
region responsible for the formation of foci using this method.

These foci

colocalized with full-length hIntS7 foci; however, the deletion mutants had a strong
nuclear presence, where the full-length protein was not seen in the nucleus. This
suggests that deletion of any part of the IntS7 protein causes it to be retained in the
nucleus to a greater extent than the full-length protein. One method in which P
bodies are thought to assemble is through the interaction of glutamine/asparagine
(Q/N) rich prion-like domains found in many P body components [102].

IntS7

contains a glutamine-rich stretch at its C-terminus, which could be responsible for
its apparent aggregation into P bodies; however, no effect was observed with the
removal of this region in our experiment.
In conclusion, this study has demonstrated the cellular localization of the
majority of the Integrator complex subunits. As expected, we have found that one
of the subunits, IntS3 localizes to the Cajal bodies in the nucleus. Unexpectedly,
however, we have shown that two of the subunits, IntS2 and 7 localize to discrete
cytoplasmic foci that colocalize to P bodies. This was the first time any Integrator
subunits have been associated with these cytoplasmic structures.

These

localizations provide clues as to the function of these Integrator subunits in snRNA
biogenesis and snRNP assembly as well as suggest the possibility of function in
other cellular processes. In addition to this, this study has also generated many
useful tools, such as the tagged Integrator clones for both human and Drosophila
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cells, that can be used to further the understanding of the Integrator complex and its
functions in the future.
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